Relating to the duties of a prescriber issuing an opioid prescription to treat acute pain.
Impact
Under the proposed changes to the Health and Safety Code, the bill also encourages prescribers to consider alternative pain management options alongside opioid prescriptions. These alternatives include chiropractic treatment, physical therapy, occupational therapies, and osteopathic manipulation, which can provide patients with various options for pain relief without solely relying on opioids. The bill does not necessitate exhausting these alternatives before prescribing opioids but positions them as considerations during treatment planning.
Summary
House Bill 1791 addresses the responsibilities of prescribers when issuing opioid prescriptions specifically to treat acute pain. The bill mandates that whenever an opioid is prescribed, the prescriber must also prescribe an opioid antagonist, which is a medication that can counteract the effects of opioids in cases of overdose. This requirement aims to mitigate the risk of opioid abuse and to enhance patient safety through better management of opioid prescriptions.
Contention
One notable point of contention surrounding HB 1791 lies in the balance between managing pain effectively and preventing opioid misuse. Supporters argue that by requiring the prescription of an opioid antagonist, the bill takes a proactive stance against the opioids' potential for dependency and overdose. However, opponents may raise concerns about the practical implications for patients requiring immediate pain relief and whether the mandated antagonist will create barriers in healthcare access or complicate the prescribing process, particularly for those with legitimate needs.
Texas Constitutional Statutes Affected
Health And Safety Code
Chapter 481. Texas Controlled Substances Act
Section: 07636
Section: New Section
Occupations Code
Chapter 554. Board Powers And Duties; Rulemaking Authority
Section: 051
Chapter 565. Disciplinary Actions And Procedures; Reinstatement Of License
Relating to the sharing of controlled substance prescription monitoring information between the Texas State Board of Pharmacy and the Health and Human Services Commission for the state Medicaid program.